BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8377719)

  • 1. [Detection of lupus anticoagulants in the routine blood coagulation laboratory exemplified by 36 patients with systemic lupus erythematosus].
    Halbmayer WM; Haushofer A; Schratzberger W; Petera P; Duschet P; Fischer M
    Med Klin (Munich); 1993 Jul; 88(7):417-22. PubMed ID: 8377719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lupus anticoagulant and antiphospholipid antibody values in a family with systemic lupus erythematosus].
    Alper G; Tavmergen EN; Ozsan H; Tavmergen E; Gümüsdis G; Onat T; Erlacin E
    Zentralbl Gynakol; 1992; 114(10):509-12. PubMed ID: 1414067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of antiphospholipid antibodies in lupus nephritis.
    Natejumnong C; Ruangkanchanasetr P; Aimpun P; Supaporn T
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S121-8. PubMed ID: 17044463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibodies in a heterogeneous group of patients: experience from a central laboratory.
    Mader R; Ziporen L; Mader R; Neumann L; Buskila D
    Clin Rheumatol; 2002 Sep; 21(5):386-90. PubMed ID: 12223987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lupus anticoagulants in patients with systemic lupus erythematosus].
    Matsuura Y; Nawata Y; Miike S; Hiraguri M; Kita Y; Kurasawa K; Takabayashi K; Oh H; Iwamoto I; Saito Y
    Ryumachi; 1996 Feb; 36(1):16-24. PubMed ID: 8711533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Laboratory diagnosis of lupus anticoagulant].
    Swadźba J; Musiał J; Jankowski M; Bednarczyk M; Dyczek A; Szczeklik A
    Pol Merkur Lekarski; 1996 Nov; 1(5):359-62. PubMed ID: 9273219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regulation of coagulo-fibrinolytic activity and lupus anticoagulants in systemic lupus erythematosus].
    Fusegawa H; Ichikawa Y; Tanaka Y; Shiba T; Kawada T; Shimizu H; Moriuchi J; Arimori S; Ando Y
    Ryumachi; 1990 Apr; 30(2):90-8. PubMed ID: 2122531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiphospholipid syndrome and stroke].
    Kitagawa Y
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incidence of selected antiphospholipid antibodies in a group of patients with systemic lupus erythematosus].
    Fojtík Z; Beránek M; Klabusay M; Korístek Z; Buliková A
    Vnitr Lek; 2004 Apr; 50(4):267-73. PubMed ID: 15214295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin generation measured ex vivo following microvascular injury is increased in SLE patients with antiphospholipid-protein antibodies.
    Musiał J; Swadźba J; Jankowski M; Grzywacz M; Bazan-Socha S; Szczeklik A
    Thromb Haemost; 1997 Oct; 78(4):1173-7. PubMed ID: 9364980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
    Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
    Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
    Arnoux D; Boutière B; Sanmarco M
    Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies--our experience.
    Srikrishna A; Sitalakshmi S; Devi S; Damodar P; Varghese J; Suresh J; Mathew T
    Indian J Pathol Microbiol; 2004 Apr; 47(2):174-7. PubMed ID: 16295461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus.
    Senécal JL; Rauch J; Grodzicky T; Raynauld JP; Uthman I; Nava A; Guimond M; Raymond Y
    Arthritis Rheum; 1999 Jul; 42(7):1347-53. PubMed ID: 10403261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH.
    Brandt JT; Triplett DA; Alving B; Scharrer I
    Thromb Haemost; 1995 Oct; 74(4):1185-90. PubMed ID: 8560433
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.